The claimEvidence B · meta-analysis
Red yeast rice = natural, safer statin
The evidence
Monacolin K is chemically identical to lovastatin — 'natural' brings dose variance + citrinin contamination.
Why the claim spreads
The word 'natural' rebrands a drug as a supplement — it sidesteps the stigma around statins and skips the prescription entirely.
The mechanism, in brief
Red Yeast Rice (RYR) is not 'rice' — it's the product of rice fermented with a red filamentous fungus:
Sources (3)
- Cohen, P. A., Avula, B., & Khan, I. A. (2017). Variability in strength of red yeast rice supplements purchased from mainstream retailers. European Journal of Preventive Cardiology, 24(13), 1431-1434. 28 brands analysed by UHPLC-DAD-QToF; monacolin K undetectable in 2, and across the remaining 26 it ranged 0.09-5.48 mg per 1200 mg of red yeast rice — 0.09 to 10.94 mg per day at the manufacturers' own recommended servings (a 120-fold spread).
- Gordon, R. Y., Cooperman, T., Obermeyer, W., & Becker, D. J. (2010). Marked variability of monacolin levels in commercial red yeast rice products: buyer beware! Archives of Internal Medicine, 170(19), 1722-1727. 12 commercial formulations assayed: total monacolins 0.31-11.15 mg/capsule, monacolin K (lovastatin) 0.10-10.09 mg/capsule; 4 of the 12 had elevated levels of the nephrotoxic mycotoxin citrinin.
- EFSA Panel on Food Additives and Nutrient Sources added to Food. (2018). Scientific opinion on the safety of monacolin K from red yeast rice. EFSA Journal, 16(8), 5368.